The Distinction
Thymosin Beta-4 (Tฮฒ4) is a naturally occurring 43-amino-acid protein present in virtually all human cells. TB-500 is a synthetic peptide corresponding to amino acids 17-23 of Thymosin Beta-4 โ specifically the actin-binding domain. It is a 7-amino-acid fragment, not the full protein.
Why the Fragment?
Researchers identified the actin-binding domain as the portion of Thymosin Beta-4 most responsible for its observed biological activity. By synthesizing just this fragment, researchers can study the mechanism more precisely, and pharmaceutical manufacturers can produce a more consistent, synthesizable compound than the full 43-amino-acid protein.
Does the Fragment Have the Same Effects?
This is the key scientific question. Research suggests the actin-binding fragment retains most of the relevant biological activity โ the effects on cell migration, wound healing, and tissue repair observed in full Thymosin Beta-4 research appear to be substantially mediated through this domain. But the full protein may have additional activities not captured by the fragment.
What This Means for Patients
When your physician prescribes TB-500, you are receiving the synthetic actin-binding fragment of Thymosin Beta-4 โ the compound with the most direct research evidence for the tissue repair applications being targeted. The distinction from full Thymosin Beta-4 is scientifically meaningful but clinically, TB-500 is the standard for this indication because of its research history and synthetic accessibility.